Dr. Harshman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Dana 1230
Boston, MA 02215Phone+1 617-632-4524- Is this information wrong?
Education & Training
- Stanford Health CareFellowship, Hematology and Medical Oncology, 2006 - 2009
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2003 - 2006
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2003
Certifications & Licensure
- CA State Medical License 2006 - Present
- FL State Medical License 2023 - 2025
- MA State Medical License 2012 - 2021
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer Start of enrollment: 2009 Oct 01
- Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer Start of enrollment: 2014 Aug 01
- Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy Start of enrollment: 2017 Apr 28
- Join now to see all
Publications & Presentations
PubMed
- Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer.Atish D Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M Allaire, Jaqueline Marquez, David D Yang, Abhishek Tripathi, Jacqueline M Kilar, Meredith Flynn, Brianna May...> ;Cancer Immunology Research. 2024 Mar 29
- 1 citationsCirculating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma.Renee Maria Saliby, Talal El Zarif, Ziad Bakouny, Valisha Shah, Wanling Xie, Ronan Flippot, Thomas Denize, M Harry Kane, Katrine N Madsen, Miriam Ficial, Laure Hirsch,...> ;Cancer Immunology Research. 2023 Aug 3
- 5 citationsMetastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective study.Cassandra Duarte, Junxiao Hu, Benoit Beuselinck, Justine Panian, Nicole Weise, Nazli Dizman, Katharine A Collier, Nityam Rathi, Haoran Li, Roy Elias, Nieves Martinez-C...> ;Eclinicalmedicine. 2023 Jun 1
- Join now to see all
Journal Articles
- Tumor Fraction in Cell-Free DNA as a Biomarker in Prostate CancerHeather A. Parsons, Atish D. Choudhury, Lauren C. Harshman, Daniel G. Stover, The Journal of Clinical Investigation
- A Dose Finding Clinical Trial of Cabozantinib (XL184) Administered in Combination with Abiraterone Acetate in Metastatic Castration‐Resistant Prostate CancerChristopher Sweeney, Lauren C Harshman, Mark Pomerantz, Brandon Bernard, Atish D Choudhury, Philip W Kantoff, The Prostate
Lectures
- PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (E...2019 ASCO Annual Meeting - 6/1/2019
- PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) vs. observation in patients with localized renal cell carcinoma (RCC) undergoing nephrec...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- 13th Multidisciplinary Management of Cancers: A Case-based ApproachStanford Hospital & Clinic, Stanford, California - 3/9/2012
Press Mentions
- The Combination of Pembrolizumab and Radium-223 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) - Atish ChouduryFebruary 26th, 2021
- Activity of Cabozantinib in Advanced Non–Clear Cell Renal Cell CarcinomaMarch 15th, 2019
- Cabozantinib Active Across Non-Clear Cell Kidney CancersMarch 6th, 2019
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: